DUBLIN, March 7, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the "Neuro Intervention Market: New Strategic Landscape & Market Forecast" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

The global neuro intervention market resumed double digit growth and is poised to surpass $1.2 billion in revenue by the end of the year.

The rollout of the much anticipated Target Tenzing family of rapid detachment embolic coils from Stryker, coupled with stellar performance from both the flow diverter and neurovascular thrombectomy devices segments contributed to overall growth.

Neurovascular Intervention Market is still undergoing consolidation with leading players acquiring innovative startups at an unprecedented rate. After Covidien's acquisition of ev3 for $2.6 billion, the company snapped Reverse Medical's line of neurovascular guide catheters.

Stryker, which became the undisputed market leader after its acquisition of Boston Scientific's neurovascular division for $1.5 billion, coughed another $130 million for Concentric Medical and announced its intentions to acquire a next generation Flow Diverter.

After acquiring Micrus Endovascular for $480 million, Codman & Shurtleff spun off its surgical instruments business to Symmetry Medical for $165m in cash in a move that would sharpen its focus on the neuro intervention space and replenish its financial war chest for targeted acquisitions.

Neuro Intervention Market Report is the latest update of Medtech Ventures best-selling strategic audit of the industry. The report analyzes revenue and growth trends for the entire sector with special emphasis on embolic coils, intracranial stents, Flow Diverters, liquid embolics and thrombectomy devices.

The report also segments the market based on disease areas with special emphasis on endovascular cerebral aneurysm repair (ECAR) and both acute and chronic cerebral ischemia.

Neuro Intervention Market Report examines Leading companies technologies, product offerings, market shares and strategic positions, uncovers areas with maturing trends as well as areas with high growth potential and provides an updated forecast to 2017.

Companies Mentioned

- Balt Extrusion
- Cardiatis
- CoAxia
- Codman Neurovascular
- Concentric Medical
- Covidien
- ev3
- Gore Medical
- ITGI Medical
- Johnson & Johnson
- Merlin MD
- MicroVention
- Micrus Endovascular
- MindFrame
- NeuroInterventions
- NeuroVasx
- Nfocus Neuromedical
- Penumbra
- Phenox GmbH
- Reverse Medical
- Sequent Medical
- Stryker
- Surpass Medical
- Terumo
- Valor Medical

For more information visit http://www.researchandmarkets.com/research/tw3x7d/neuro

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System

SOURCE Research and Markets